Syngene International inks pact with Deerfield Discovery and Development Corporation

20 Nov 2020 Evaluate

Syngene International and Deerfield Discovery and Development Corporation (3DC), the drug discovery and development subsidiary of Deerfield Management Company (Deerfield), have signed an agreement to collaborate to advance therapeutic discovery projects, from target validation through to pharmacological proof of concept and preclinical evaluation.

This five-year collaboration unites the core skills of the investment management company Deerfield, through its drug discovery and development arm 3DC, and Syngene’s integrated drug discovery (IDD) services.

Syngene International is India’s largest Contract Research Services Organization providing integrated discovery and development services for novel molecules across multiple platforms including small molecules, large molecules, Antibody-Drug Conjugates and Oligonucleotides.

Syngene Internation. Share Price

862.60 2.75 (0.32%)
01-Nov-2024 18:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 862.60
AGS Transact Tech 96.36
Just Dial 1141.00
Krystal Integrated 716.70
Latent View Analytic 461.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.